The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
The cover story explores what prison-based programs are available to help incarcerated parents and their children. Another feature examines ways to help social media users navigate the online extremist ecosystem.
Failure to recognize and respond to how rapidly illegal drug markets have changed with the arrival of illegally manufactured synthetic opioids will continue to put many Americans at risk of exposure to fentanyl, endangering the lives of hundreds of thousands more for years to come.
This weekly recap focuses on why it may be time to consider a peacekeeping operation in northern Ukraine, supporting veterans with traumatic brain injury, a new response to synthetic opioids, and more.
For decades, elected officials brushed off harm reduction as a viable option for reducing the harms of drug use over concerns of enabling drug consumption. But now, these strategies are front and center, spoken aloud, from the largest podium in the land, and during prime time. What caused this historic about-face?
The opioid crisis isn't just about drug policy or law. It involves national security, homeland security, intelligence, diplomacy, supply chain issues, and cryptocurrency. Drawing on RAND's expertise across all those areas, the Commission on Combating Synthetic Opioid Trafficking delivered a plan, a call to action about what it's going to take to save lives.
This study examined the rates of subsequent buprenorphine treatment for buprenorphine-naïve individuals filling buprenorphine prescriptions from emergency physicians and initiated buprenorphine treatment and how such rates varied before and during the COVID-19 pandemic.
Most people who fill prescriptions from emergency physicians to treat their opioid use disorder do not continue to receive the medication, suggesting new approaches are needed to help people continue drug treatment begun on an emergency basis.
Synthetic opioids are likely to increasingly reach illegal drug markets. Failure to recognize and respond to how rapidly drug markets have changed with the arrival of illegally manufactured synthetic opioids will continue to put many at risk of exposure to fentanyl, endangering the lives of hundreds of thousands more Americans for years to come.
Pain is the leading cause of disability among active-duty service members. Given its potential impact on well-being and force readiness, providing high-quality treatment is a strategic priority. An assessment of outpatient care for acute and chronic pain, including opioid prescribing, can help the MHS continue to improve care.
This study demonstrates the differences in surveillance methodology for concurrent drug abuse epidemics using hospital claims and PC data. Both systems provide incomplete reports, but in combination can provide a more complete picture.
We compared Colorado's all-payer claims databases with other state-level databases, using analyses comparing quarterly rates of opioid-involved inpatient and emergency department visits and rates of 30-day opioid fills.